Tower Research Capital LLC (Trc) Ikena Oncology, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,875 shares of IKNA stock, worth $2,681. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,875
Previous 20,132
90.69%
Holding current value
$2,681
Previous $33,000
90.91%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IKNA
# of Institutions
61Shares Held
30.4MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$7.18 Million1.36% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$6.82 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.85 Million2.33% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$5.13 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.06 Million0.14% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $51.8M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...